Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
success sector : Professional, scientific, and technical services save search
Global mRNA Vaccine Market Research Report 2023-2028: COVID-19 Success Opens New Avenues with with 444 Ongoing Clinical Studies Worldwide
Published: 2023-11-08 (Crawled : 03:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.91%
H: 0.0%
C: 0.0%
VERV | News | $6.64 -0.3% -0.3% 1.1M
|
Professional, Scientific, and T...
|
| O: 0.37%
H: 0.64%
C: -10.76%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.46%
H: 0.46%
C: -0.23%
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: -0.01%
H: 0.03%
C: -3.14%
CVAC | $2.44 0.0% 790K
|
Health Technology
|
| O: 0.91%
H: 1.08%
C: -1.44%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 0.13%
H: 0.08%
C: -2.81%
ARCT 4 | $25.995 -1.23% -1.25% 630K
|
Health Technology
|
| O: -0.36%
H: 0.79%
C: -0.61%
covid-19 success report vaccine mrna worldwide ongoing research global market
TransCode Therapeutics Reports Successful Treatment of Preclinical Melanoma Tumors with its Immunotherapy Candidate, TTX-RIGAStudy showed a 70% Inhibition of Recurrent Tumor Growth
Published: 2023-10-16 (Crawled : 19:00) - biospace.com/
RNAZ | $0.49 -2.39% -2.45% 110K
|
Professional, Scientific, and T...
|
| O: 14.24%
H: 7.44%
C: -7.36%
melanoma tumors treatment tumor preclinical immunotherapy therapeutics growth
TransCode Therapeutics Reports Successful Treatment of Preclinical Melanoma Tumors with its Immunotherapy Candidate, TTX-RIGA
Published: 2023-10-16 (Crawled : 12:00) - globenewswire.com
RNAZ | $0.49 -2.39% -2.45% 110K
|
Professional, Scientific, and T...
|
| O: 14.24%
H: 7.44%
C: -7.36%
melanoma tumors treatment preclinical immunotherapy therapeutics
Acurx Pharmaceuticals Announces Successful Completion and Early Discontinuation of the Ibezapolstat Phase 2b Trial for Treatment of C. difficile Infection
Published: 2023-10-02 (Crawled : 11:00) - prnewswire.com
ACXP | $2.02 -5.16% -5.45% 94K
|
Professional, Scientific, and T...
|
| O: 4.67%
H: 3.82%
C: -10.19%
ibezapolstat infection treatment pharmaceuticals trial
1847 Holdings Announces Successful Restructuring of Promissory Notes to Non-Dilutive Debt Instruments
Published: 2023-08-31 (Crawled : 14:30) - globenewswire.com
EFSH 4 | $2.1 21.39% 2.86% 250K
|
Professional, Scientific, and T...
|
| O: 3.82%
H: 69.97%
C: 18.04%
Pyxis Oncology Successfully Completes Acquisition of Apexigen
Published: 2023-08-23 (Crawled : 12:30) - globenewswire.com
PYXS | $4.155 -8.28% -9.03% 670K
|
Professional, Scientific, and T...
|
| O: 1.35%
H: 7.96%
C: 5.31%
acquisition
Zura Bio's Veteran Leadership Eyes Repeat Success, Confident Analyst Sees 150% Upside – Zura Bio (NASDAQ: – Benzinga
Published: 2023-05-24 (Crawled : 19:00) - spacfeed.com
ARIZ | $6.03 12.6% 73K
|
|
| O: 4.48%
H: 0.0%
C: -5.27%
PYXS | $4.155 -8.28% -9.03% 670K
|
Professional, Scientific, and T...
|
| O: -1.2%
H: 0.61%
C: -5.91%
Zentek Announces Successful Phase 2 Results of HVAC Testing
Published: 2022-12-15 (Crawled : 13:20) - biospace.com/
ZTEK | $1.14 1.33% 13K
|
Professional, Scientific, and T...
|
| O: 2.89%
H: 0.0%
C: -6.74%
IKTSY | News | $59.97 -12.21% 88K
|
Professional, Scientific, and T...
|
| O: -1.86%
H: 0.0%
C: -0.96%
results phase 2
BriaCell Announces Successful Completion of Phase I Portion of Clinical Study in Advanced Breast Cancer; Randomized Phase II Efficacy Evaluation Progressing
Published: 2022-10-21 (Crawled : 13:20) - globenewswire.com
BCTX | $2.19 -5.6% -5.94% 140K
|
Professional, Scientific, and T...
|
| O: 1.12%
H: 1.1%
C: -1.43%
breast study
Connect BioPharma Successfully Completes CBP-174 Phase 1 Single Ascending Dose Study
Published: 2022-08-30 (Crawled : 13:20) - biospace.com/
CNTB | $1.49 -1.97% -2.01% 32K
|
Professional, Scientific, and T...
|
| O: 0.35%
H: 1.39%
C: -2.08%
cbp-174 biopharma study phase 1
omniQ’s AI-Based Vehicle Recognition Technology to Be Installed in an Additional City in Georgia Following Recent Success in Adrian, Georgia
Published: 2022-01-28 (Crawled : 14:00) - globenewswire.com
OMQS | $0.4533 -15.65% -18.55% 340K
|
Professional, Scientific, and T...
|
| O: -2.4%
H: 0.0%
C: -5.53%
ces technology success
VectivBio Announces Successful Opening of US IND for Apraglutide for Acute Graft-Versus-Host Disease
Published: 2021-10-20 (Crawled : 21:00) - biospace.com/
VECT | $16.85 0.12% 130K
|
Professional, Scientific, and T...
|
| O: 4.73%
H: 2.56%
C: -5.11%
disease
Miromatrix Announces the First Successful Transplant of a Bioengineered Whole Organ in a Large Animal
Published: 2021-10-07 (Crawled : 10:00) - globenewswire.com
MIRO | $3.39 3.25% 630K
|
Professional, Scientific, and T...
|
| O: 2.86%
H: 2.49%
C: -0.73%
Werewolf Therapeutics Appoints Mike Sherman to its Board of DirectorsOver 30 years of experience in advancing therapeutics to commercial launch and driving companies to successful operations and strategic transactions
Published: 2021-05-28 (Crawled : 12:00) - biospace.com/
HOWL | $5.91 0.68% 0.68% 120K
|
Professional, Scientific, and T...
|
| O: 0.21%
H: 4.02%
C: 1.5%
BSX | $67.33 -0.13% -0.31% 7M
|
Health Technology
|
| O: 0.95%
H: 1.18%
C: 0.45%
CMRX | $0.8844 -5.14% -5.42% 430K
|
Health Technology
|
| O: 0.0%
H: 2.9%
C: -1.51%
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.